These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 3090830

  • 1. Antithrombin III during high-dose cytosine arabinoside therapy with or without asparaginase.
    Marra R, Pagano L, De Stefano V, Leone G, Bizzi B.
    Acta Haematol; 1986; 75(2):96-9. PubMed ID: 3090830
    [Abstract] [Full Text] [Related]

  • 2. [Sequential combination of high-dose cytosine arabinoside and L-asparaginase in the treatment of refractory acute leukemia and malignant lymphoma].
    Shimazaki C, Fujita N, Nakanishi S, Nishio A, Haruyama H, Nakagawa M, Ijichi H.
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2202-7. PubMed ID: 3864396
    [Abstract] [Full Text] [Related]

  • 3. Sequential high-dose cytosine arabinoside and L-asparaginase in childhood leukemia in relapse.
    Ettinger LJ, Biener R, Finklestein JZ, Kamalakar P, Jones GR, Avramis VI, Holcenberg JS.
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):155-9. PubMed ID: 3859930
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase.
    Capizzi RL, Poole M, Cooper MR, Richards F, Stuart JJ, Jackson DV, White DR, Spurr CL, Hopkins JO, Muss HB.
    Blood; 1984 Mar; 63(3):694-700. PubMed ID: 6696996
    [Abstract] [Full Text] [Related]

  • 5. Sequential high-dose cytosine arabinoside-asparaginase treatment in advanced childhood leukemia.
    Wells RJ, Feusner J, Devney R, Woods WG, Provisor AJ, Cairo MS, Odom LF, Nachman J, Jones GR, Ettinger LJ.
    J Clin Oncol; 1985 Jul; 3(7):998-1004. PubMed ID: 3860629
    [Abstract] [Full Text] [Related]

  • 6. Depression of functional and antigenic plasma antithrombin III (AT-III) due to therapy with L-asparaginase.
    Liebman HA, Wada JK, Patch MJ, McGehee W.
    Cancer; 1982 Aug 01; 50(3):451-6. PubMed ID: 7046902
    [Abstract] [Full Text] [Related]

  • 7. [High-dose cytosine arabinoside and L-asparaginase in the treatment of refractory or recurrent acute non-lymphoblastic leukemia].
    Sanz MA, Borrego D, Martín-Aragonés G, Martínez JA, Lorenzo I, Sanz G, Sayas MJ, Jarque I, Pastor E, Rafecas J.
    Sangre (Barc); 1987 Aug 01; 32(4):476-81. PubMed ID: 3660187
    [No Abstract] [Full Text] [Related]

  • 8. [Intermediate-dose cytosine arabinoside therapy in refractory acute leukemia].
    Ohshima A, Yoshida K, Miyazaki S, Fukushima Y, Miura AB, Endo K, Ando H, Sasaki H, Saito S, Sato I.
    Gan To Kagaku Ryoho; 1989 Jan 01; 16(1):139-42. PubMed ID: 2643393
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Sequential high-dose cytarabine therapy in combination with asparaginase in acute myeloid leukemia].
    Radtke H, Pees HW, Schwamborn J, Thumser B, Daus H.
    Onkologie; 1988 Dec 01; 11(6):276-81. PubMed ID: 3071762
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia.
    Capizzi RL, Powell BL, Cooper MR, Stuart JJ, Muss HB, Richards F, Jackson DV, White DR, Spurr CL, Zekan PJ.
    Semin Oncol; 1985 Jun 01; 12(2 Suppl 3):105-13. PubMed ID: 3892697
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effective combination treatment of advanced acute lymphocytic leukemia with cytosine arabinoside (NSC-63878) and L-asparaginase (NSC-109229).
    Ortega JA, Finklestein JZ, Ertel I, Hammond D, Karon M.
    Cancer Chemother Rep; 1972 Jun 01; 56(3):363-8. PubMed ID: 19051496
    [Abstract] [Full Text] [Related]

  • 18. Intensive treatment of stage III-IV aggressive malignant lymphomas (protocol TPL-84).
    Colombat P, Guilhot F, Bordesoule D, Renou P, Benz-Lemoine E, Fouillard L, Drouet M, Tanzer J, Lamagnere JP.
    Haematologica; 1991 Jun 01; 76(6):479-84. PubMed ID: 1726492
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Decreases in plasma antithrombin III, fibrinogen, factor IX, X and XI, fibronectin and thyroxine binding globulin during therapy with L-asparaginase, vincristine and prednisolone in a patient with CML blastic crisis].
    Nishino H, Miura S, Hirai Y, Shigekiyo T, Kawauchi S, Takeichi T, Shirakami A, Saito S.
    Rinsho Ketsueki; 1984 Jun 01; 25(6):882-7. PubMed ID: 6434766
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.